Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a series of papers that reflect the current research focus and interests of the EuroQol Group.
SPOR—the professional society for health economics and outcomes research (HEOR), announced today the release of its 2019 Top 10 HEOR Trends report. For the second year, based on a survey of its members, the Society has identified the top 10 HEOR trends that will shape the field in the near future.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research describing a method to predict generic entry of top-selling drugs and a formal assessment of its accuracy.
Value in Health, the official journal of ISPOR, announced today the publication of new research finding that of 20 quality of life (QoL) instruments tested, only two (KIDSCREEN and KINDL) are recommended for service providers to measure the QoL of children with a disability.
Value in Health Regional Issues, the regionally focused online journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a series of 4 articles describing current drug policy in Estonia, Romania, Greece, and the Russian Federation.
Value in Health, the official journal of ISPOR, announced today the publication of new research showing that the lowest priced generic drugs are at a substantially elevated risk of experiencing a drug shortage, and that periods of drug shortages are associated with only modest increases in drug prices.
Value in Health announced the publication of new research showing that the Diabetes Medication System Rating Questionnaire and the Diabetes Medication System Rating Questionnaire-Short Form are the preferred survey instruments for measuring medication satisfaction in patients with type 2 diabetes using oral therapy in clinical trials.
ISPOR—the professional society for health economics and outcomes research, has received multiple MarCom Awards for its new organizational rebranding, newly redesigned website, and a number of other communications initiatives.
ISPOR CEO and Executive Director Nancy S. Bergwas recently honored with 3 Stevie Awards®. The Stevie Awards for Women in Business are the world’s top honors for female entrepreneurs, executives, employees, and the organizations they run.
ISPOR Europe 2018 concluded yesterday in Barcelona, Spain with record attendance. The Society had 5507 total attendees register for the event—the largest for any of its conferences to date.
ISPOR Europe 2018 session addresses challenges to open science, including data sharing, replication, and robustness of evidence from real-world data.
The third plenary of ISPOR Europe 2018 focused on the issue of budget impact and expenditure caps in healthcare.
A session at ISPOR Europe 2018 reported on the progress on its ISPOR Health Economics and Outcomes Research Competencies Framework™ initiative.
A session at ISPOR Europe 2018 explored how patient engagement is transforming healthcare.
ISPOR, the professional society for health economics and outcomes research (HEOR), presented a number of honorees with its annual HEOR awards this morning at ISPOR Europe 2018.
A session at ISPOR Europe 2018 explored the issue of valuing a cure in healthcare.
The second plenary at ISPOR Europe 2018, “Pharmaceutical Pricing: The Many Faces of Fairness,” sought to define “fair” in the context of pharmaceutical pricing.
ISPOR Europe 2018 session explored the evolving European Union policy landscape with panelists discussing if Europe is on the right path to improve outcomes research of medical devices.
ISPOR Europe 2018 session explored health technology assessment value-based pricing versus WHO fair pricing to assess which approach best delivers universal health coverage.
A session, “Healthcare X.0: Digital Technologies and Creation of Value,” at ISPOR Europe 2018 explored how digital technologies are creating the next generation healthcare system in Europe and beyond.
ISPOR Europe 2018 session, “Will Machines Soon Make Health Economists Obsolete?” explored the impact of machine learning on health economics.
ISPOR Europe 2018 opened this morning with its first plenary, “Joint Assessment of Relative Effectiveness: ‘Trick or Treat’ for Decision Makers in the EU Member States,” a session on the impact of the European Commission’s Draft Regulation on health technology assessment.
ISPOR, the professional society for health economics and outcomes research (HEOR), released the final program and speakers for its upcoming ISPOR Europe 2018 conference scheduled for 10-14 November in Barcelona, Spain.
Value in Health, the official journal of ISPOR, announced today the publication of 2 studies confirming the value of including patients and other nonscientists in the process for approving research funding.
ISPOR—the professional society for health economics and outcomes research, announced today the publication of new recommendations for economic analysis of vaccination programs given limited resources and budgets.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research showing that Medicare Part D prescription plans with higher generic drug use have higher summary star ratings and improved member experience.
ISPOR—the professional society for health economics and outcomes research (HEOR), has published a new Good Practices for Outcomes Research Report that illustrates how constrained optimization methods can be used to assess the value of health technologies.
ISPOR, the professional society for health economics and outcomes research, announced the full program and speakers for the upcoming ISPOR Summit 2018, “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare,” scheduled for October 19, 2018 in Washington, DC, USA.
ISPOR, the professional society for health economics and outcomes research (HEOR), announced that it has published a new Global Healthcare Systems Road Map—Egypt Pharmaceuticals.
ISPOR, the professional society for health economics and outcomes research, announced plenary sessions and speakers for ISPOR Europe 2018, “New Perspectives for Improving 21st Century Health Systems." The conference is scheduled for 10-14 November in Barcelona, Spain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right